参考文献
|
-
Böhm, M,Borer, J,Ford, I(2013).Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.Clin Res Cardiol,102,11-22.
-
Cleland, JGF,Calvert, MJ,Verboven, Y(2009).Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the Cardiac Resynchronisation-Heart Failure (CARE-HF) study.Am Heart J,157,457-466.
-
Cohn, JN,Archibald, DG,Ziesche, S(1986).Effect of vasodilator therapy on mortality in chronic congestive heart failure.N Engl J Med,314,1547-1552.
-
Faris, RF,Flather, M,Purcell, H(2012).Diuretics for heart failure.Cochrane Database Syst Rev,2,CD003838.
-
Garg, R,Yusuf, S(1995).Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure.JAMA,273,1450-1456.
-
Granger, CB,McMurray, JJV,Yusuf, S(2003).Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.Lancet,362,772-776.
-
Hjalmarson, A,Goldstein, S,Fagerberg, B(2000).Effects of controlled-release metoprolol on total mortality, hospitalizations, and wellbeing in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF).JAMA,283,1295-1302.
-
King, JB,Bress, AP,Reese, AD(2015).Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review.Pharmacother J Hum Pharmacol Drug Ther,35,823-837.
-
McMurray, JJ,Packer, M,Desai, AS(2014).PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure.N Engl J Med,371,993-1004.
-
Packer, M,Coats, AJ,Fowler, MB(2001).Effect of carvedilol on survival in severe chronic heart failure.N Engl J Med,344,1651-1658.
-
Packer, M,Poole-Wilson, PA,Armstrong, PW(1999).Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure.Circulation,100,2312-2318.
-
Piotr, P,Andriaan, AV,Stefan, DA(2016).2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J,37,2129-2200.
-
Pitt, B,Zannad, F,Remme, WJ(1999).The effect of spironolactone on morbidity and mortality in patients with severe heart failure.N Engl J Med,341,709-717.
-
Sohaib, SMMA,Finegold, JA,Nijjer, SS(2015).Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials.JACC Heart Fail,3,327-336.
-
SOLVD Investigattors(1991).Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.N Engl J Med,325,293-302.
-
Taylor, AL,Ziesche, S,Yancy, C(2004).Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.N Engl J Med,351,2049-2057.
-
Torp-Pedersen, C,Metra, M,Spark, P(2007).The safety of amiodarone in patients with heart failure.J Card Fail,13,340-345.
-
Wyse, DG,Friedman, PL,Epstein, AE(1997).A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.N Engl J Med,337,1576-1583.
-
Zannad, F,McMurray, JJV,Krum, H(2011).Eplerenone in patients with systolic heart failure and mild symptoms.N Engl J Med,364,11-21.
|